您现在的位置: 首页> 研究主题> 肝炎,戊型

肝炎,戊型

肝炎,戊型的相关文献在1997年到2021年内共计118篇,主要集中在内科学、临床医学、预防医学、卫生学 等领域,其中期刊论文110篇、专利文献930963篇;相关期刊51种,包括国际流行病学传染病学杂志、疾病监测、中华预防医学杂志等; 肝炎,戊型的相关文献由430位作者贡献,包括孟继鸿、戴星、董晨等。

肝炎,戊型—发文量

期刊论文>

论文:110 占比:0.01%

专利文献>

论文:930963 占比:99.99%

总计:931073篇

肝炎,戊型—发文趋势图

肝炎,戊型

-研究学者

  • 孟继鸿
  • 戴星
  • 董晨
  • 李卓
  • 王佑春
  • 郝娃
  • 严艳
  • 夏宁邵
  • 姜庆五
  • 殷继明
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 徐少保; 高人焘; 徐瑗瑗
    • 摘要: 目的 总结老年戊型肝炎患者的临床、血生化以及免疫指标的特征. 方法 回顾性分析2015年1月至2018年12月我院收治的223例戊型肝炎患者,根据年龄将其分为老年组(年龄≥60岁)与非老年组,比较两组戊型肝炎患者的临床特征、血生化以及免疫指标的差异. 结果 共有101例老年戊型肝炎患者和122例非老年戊型肝炎患者纳入分析,两组患者年龄分别为(68.9±6.6)岁和(46.2±8.8)岁.两组患者性别、住院时间、是否伴有黄疸、腹水以及腹痛、院内死亡以及其他合并疾病的差异均无统计学意义(均P>0.05);但与非老年组总胆红素56.7(134.8)μmol/L、直接胆红素37.7(110.4)μmol/L、间接胆红素15.2(25.0)μmol/L、谷氨酰转肽酶127.5(176.2)U/L、白蛋白36.9(6.2)g/L比较,老年组患者的胆红素水平更高、谷氨酰转肽酶和白蛋白水平更低.总胆红素140.4(263.8)μmol/L、直接胆红素105.9(199.0)μmol/L、间接胆红素24.7(488.0)μmol/L、谷氨酰转肽酶98.0(113.0)U/L、白蛋白32.2(8.2)g/L(Z=3.289、3.111、2.505、2.117、5.484,P=0.001、0.002、0.012、0.034、0.000),其余血生化指标比较差异均无统计学意义(均P>0.05).在免疫指标上,与非老年组患者7.9(24.4)比较,老年组患者具有更高的抗戊型肝炎病毒IgM 17.3(53.0)(Z=2.351,P=0.019),而抗戊型肝炎病毒IgG阳性率两组患者比较差异无统计学意义(x2=1.284,P=0.526). 结论 老年戊型肝炎患者的某些血生化与免疫指标显著不同于非老年患者,但临床特征未见不同,临床诊疗过程中应考虑相关指标的变化.
    • 李熹娟; 杨建柳; 杨雪; 张亚楠
    • 摘要: 目的:了解北京市某社区食品及公共场所从业人员甲型病毒性肝炎(简称甲肝)、戊型病毒性肝炎(简称戊肝)感染情况,以便为此类疾病的预防控制提供科学依据.方法:采集受检者静脉血,用酶联(ELISA)法检测甲肝、戊肝IgM(HAV-lgM、HEV-lgM).结果:2017年1月-2018年9月对北京市某社区食品和公共场所从业人员体检共16022人,检出HAV-IgM阳性43人,阳性率为0.27%;检出HEV-IgM阳性55人,阳性率0.34%.两年间HAV-IgM检测的阳性率呈下降趋势,差异无统计学意义(χ2=0.158,P>0.05);但2018年HEV-IgM检测的阳性率显著低于2017年,差异有统计学意义(χ2=8.960,P<0.01).另外,男、女性的HAV-IgM阳性率分别为0.32%、0.22%,HEV-IgM阳性率分别为0.36%、0.33%,不同性别的HAV-IgM、HEV-IgM阳性率均无统计学差异.食品、公共场所从业人员的HAV-IgM阳性率分别为0.26%、0.29%,HEV-IgM阳性率分别为0.34%、0.35%,两种职业群体的HAV-IgM、HEV-IgM阳性率均无统计学差异.结论:该社区食品及公共场所从业人员发现了少部分甲肝、戊肝患者,虽无任何临床症状,但为排除潜在传染源,更好地对食品及公共场所进行监督管理,所以相关从业人员预防性健康体检非常必要.
    • 蒋煜; 徐飞; 胡居龙; 华文浩; 李坪; 魏红山
    • 摘要: 目的 观察戊型肝炎患者血清GP73变化特征.方法 分析80例健康体检者(对照组)和66例戊型肝炎患者(观察组)血清GP73水平的变化.结果 对照组研究对象血清GP73水平为(38.82±15.67)ng/ml,观察组患者血清GP73为(80.06±52.33)ng/ml,较对照组显著升高,差异具有统计学意义(t=6.785、P<0.001);患者血清GP73水平与丙氨酸氨基转移酶(ALT)活性(r=0.28、P=0.015)、天门冬氨酸氨基转移酶(AST)活性(r=0.36、P=0.002)总胆红素(TBil)水平(r=0.47、P<0.001)均呈正相关,而与凝血酶原活动度(PTA)水平呈负相关(r=-0.329、P=0.004).结论 血清GP73显著升高的人群需考虑急性戊型肝炎病毒感染的可能.戊型肝炎患者的血清GP73水平可能与肝功能损伤程度具有一定的相关性.%Objective To investigate the variable characteristics of serum GP73 for patients with hepatitis E.Methods The changes of GP73 level in serum of 80 healthy subjects (control group) and 66 patients with hepatitis E were detected by quantitative enzyme-linked immunosorbent assay.Results The median level of serum GP73 for patients with hepatitis E (80.06 ± 52.33 ng/ml) was significantly increased than that of 80 healthy control subjects (38.82 ± 15.67 ng/ml), with significant difference (t= 6.785,P < 0.0001). The level of serum GP73 in patients with hepatitis E had positive correlation with the serum activity of alanine aminotransferase (ALT) (r = 0.28,P = 0.015), aspartate aminotransferase (AST) (r = 0.36,P = 0.002) and the level of serum total bilirubin (TBil) (r = 0.47,P < 0.001). While it had negative correlation with the prothrombin time activity (PTA) (r =-0.329,P = 0.004).Conclusions The possibility of acute hepatitis E infection should be considered for those who with significangly elevated serum GP73. Serum GP73 levels in patients with hepatitis E may be correlated with liver damage.
    • 赵一鸣; 刘秀红; 李伟华; 刘晓霓; 李宁
    • 摘要: 全球每年约2000万人感染戊型肝炎病毒(HEV),虽然戊型肝炎病死率在一般人群中低于1%,但HEV感染妊娠患者的病死率可高达30%.此外,免疫功能低下人群(器官移植、放化疗和HIV感染等)HEV感染所导致的慢性戊型肝炎给临床治疗带来新的问题和挑战.过去仅有戊型肝炎病例输入的发达国家,近年来亦频繁出现本土散发病例,HEV感染已成为全球重要的公共卫生问题.本文关注近两年来的研究数据,回顾HEV生物学、流行病学特征、肝外表现、治疗及诊断的最新进展,阐明戊型肝炎的研究方向是在与人类生活密切接触的偶蹄类动物中寻找新orthohepevirus基因型;更好地了解准包膜HEV(eHEV)包膜起源和结构以及参与eHEV释放和重返细胞宿主因素/途径,有助于靶向治疗性干预.
    • 郑全良; 李淑波; 刘建军; 庞武元; 张钰; 梁星辰
    • 摘要: 目的 对北京市昌平区2014—2016年食品卫生、公共场所从业人员的预防性健康体检结果进行汇总.方法 将辖区2014—2016年从业人员健康体检数据从北京市公共卫生信息管理系统导出,并进行综合统计分析.结果 预防性健康体检294598例,传染病总检出242例,平均阳性检出率为0.082%.3年间传染病检出率分别为0.058%、0.048%、0.140%,各年度检出率比较,差异均有统计学意义(χ2=58.70,P0.05).女性从业人员体检合格率高于男性,差异有统计学意义(χ2=135.20,P<0.01).结论 昌平区从业人员甲肝、戊肝检出率较高,活动性肺结核检测率也应引起重视;昌平区从业人员健康状况影响因素可能包括从业人员性别.对食品卫生、公共场所行业从业人员应坚持一年一次的健康体检,对检出传染病的从业人员应调离相关岗位.
    • 陈冲; 章树业; 荀静娜; 张玉玲; 李微霞; 卢川; 陈良
    • 摘要: 目的 探讨杀伤性免疫球蛋白样受体(KIR)及其配体人类白细胞抗原(HLA)的基因多态性与散发性急性戊型肝炎(AHE)的相关性.方法 收集2015年8月-2016年9月期间于复旦大学附属公共卫生临床中心肝炎一科住院的AHE患者42例,另招募健康受试者30例作为对照组.提取入组对象外周血基因组DNA,采用序列特异性引物PCR法扩增KIR基因,并利用Sanger测序法对HLA进行基因分型,分析KIR-HLA分布与散发性AHE的关系.计数资料组间比较采用x2检验.结果 两组均可检测到16种KIR基因(包括抑制型受体基因2DL1-3、2DL5、3DL1-3,激活型受体基因2DS1-5、3DS1,较特殊的抑制型/激活型受体基因2DL4,内参基因DRB1及假基因2DP1),同时HLA-B(包括HLA-Bw4、HLA-Bw6、HLA-Bw4/Bw6)、HLA-C(包括HLA-C1/C1、HLA-C1/C2、HLA-C2/C2)亦可检测.AHE患者中抑制型基因KIR 2DL3/2DL5/3 DL2/3 DL3出现的频率显著低于对照组(64.3% vs 93.3%,P<0.05;23.8% vs56.7%,P<0.05;71.4% vs 100%,P<0.05;69.0%vs 100%,P<0.05);AHE患者HLA-C1/C2和3DL1/HLA-Bw4基因的出现频率低于对照组(19.0% vs 40.0%,P<0.05;45.2% vs 73.3%,P<0.05);另外,AHE患者中HLA-C1/C1基因出现的频率高于对照组(71.4% vs 46.7%,P<0.05).结论 抑制型基因KIR 2DL3/2DL5/3 DL2/3DL3,HLA-C1/CI、C1/C2和3DL1/HLA-Bw4的基因分布差异可能与HEV感染导致散发性AHE有一定关系.%Objective To investigate the association between killer cell immunoglobulin-like receptor (KIR)/human leukocyte antigen (HLA) gene polymorphisms and sporadic acute hepatitis E (AHE).Methods A total of 42 AHE patients who were hospitalized in First Department of Hepatitis,Public Health Clinical Center Affiliated to Fudan University,from August 2015 to September 2016 were enrolled,and 30 healthy subjects were enrolled as control group.Genomic DNA was extracted from the peripheral blood,and PCR/sequence specific primer was used for the amplification of KIR gene.Sanger sequencing was used to determine the genotype of HLA,and the association between KIR-HLA distribution and sporadic AHE was analyzed.The chi-square test was used for comparison of categorical data between groups.Results A total of 16 KIR genes were detected in each group,including inhibitory receptor genes 2DL1-3,2DL5,and 3DL1-3,activating receptor genes 2DS1-5 and 3DS1,the special inhibitory/activating receptor gene 2DI4,internal reference gene DRB1,and pseudogene 2DP1,as well as HLA-B (including HLA-Bw4,HLA-Bw6,and HLA-Bw4/Bw6) and HLA-C (including HLA-C1/C1,HLA-C1/C2,and HLA-C2/C2),were also detected.Compared with the control group,the AHE group had significantly lower frequencies of inhibitory genes KIR 2DL3 (64.3% vs 93.3%,P < 0.05),2DL5 (23.8% vs 56.7%,P < 0.05),3DL2 (71.4% vs 100%,P < 0.05),and 3 DL3 (69.0% vs 100%,P < 0.05),significantly lower frequencies of HLA-C1 C2 (19.0% vs 40.0%,P < 0.05) and 3DL1/HLA-Bw4 (45.2% vs 73.3%,P < 0.05),and a significantly higher frequency of HLA-C1/C1 gene (71.4% vs 46.7%,P <0.05).Conclusion The difference in the distribution of inhibitory genes KIR 2DL3,2DL5,3DL2,and 3DL3,HLA-C1C1/C1C2,and 3DL1/HLA-Bw4 may be associated with sporadic AHE caused by hepatitis E virus infection.
    • 颜丙玉; 张丽; 吕静静; 冯艺; 刘甲野; 吴文龙; 宋立志; 徐爱强
    • 摘要: Objective To analyze the sero-epidemiological characteristics of hepatitis E virus (HEV) in Shandong province, and thereby to provide evidence for the policy-making of hepatitis E prevention and control. Methods The inhabitants aged between 1-59 years old were randomly selected to participate in the study by two-stage stratified random sampling method from 12 counties in Shandong province in October, 2014. Firstly two townships were selected from each county by probability proportional to size sampling (PPS) method. A total of 5229 participants aged 1-59 years old were selected by stratified random sampling method. All the participants finished a questionnaire survey and a venous blood sample (3-5 ml) was collected from each to test anti-HEV IgG by enzyme-linked assay (ELISA). The weighted prevalence of anti-HEV IgG with different demographic characteristics was estimated. The variance of the positive rate of anti-HEV IgG was calculated by Taylor series linearization method, as well as its 95%CI. A statistical test was conducted to compare the rate of its 95%CI, and the results in the present study were compared with those in sero-survey in 2006. Results A total of 5229 subjects entered the final analysis in 2014. The overall weighed prevalence of anti-HEV IgG was 9.19% (95%CI: 6.18%-12.20%) among natural population in Shandong province, decreased by 19.88% in comparison with that in 2006 sero-survey (11.47%,95%CI: 8.92%-14.02%). The prevalence increased with age increasing(χ2trend=288.11,P<0.001)in 2014, which was similar to the result in 2006 sero-survey. Except for 1-4 years old group, the prevalence of anti-HEV IgG in the other age groups were lower than it in the corresponding groups in 2006. The prevalence of anti-HEV IgG in urban (8.19%, 95%CI:0.00-22.23%), rural areas (9.69%, 95%CI:4.99%-14.38%), eastern areas (12.70%, 95%CI: 0.00-27.72%), central areas (4.74%, 95%CI: 0.00-9.91%) and western areas (9.32%, 95%CI:0.69%-17.94%) in 2014 were all lower than the corresponding prevalences (11.39%, 95%CI: 8.17%-14.62%; 11.92%, 95%CI: 8.75%-15.08%; 22.77%, 95%CI: 14.99%-30.55%; 7.97%, 95%CI: 4.75%-11.20%;10.59%, 95%CI:6.37%-14.82%) in 2006 survey. The prevalence of anti-HEV IgG in coastal areas (16.56%, 95%CI:12.94%-20.18%) and inland areas (7.63%,95%CI:5.16%-10.10%)in 2014 were lower than it in the corresponding areas (28.04%, 95%CI:20.45%-35.64%;9.50%, 95%CI:7.31%-11.70%)in 2006 survey. The prevalence among peasant (11.98%, 95%CI: 8.20%-15.76%), worker (9.68%, 95%CI:4.48%-14.88%), cadre (13.90%, 95%CI: 7.47%-20.33%), service provider (12.26%, 95%CI: 1.80%-22.73%) in 2014 survey were lower than it among the corresponding populations (13.76%, 95%CI:10.15%-17.38%;21.11%, 95%CI:12.67%-29.55%;17.81%, 95%CI:7.63%-28.00%;21.08%, 95%CI:0.03%-42.12%) in 2006 survey. Conclusion The prevalence of anti-HEV IgG has decreased in Shandong province in the recent years, but the epidemiological characteristics found no obvious changes. HEV susceptibility in natural population was generally high. Hepatitis E vaccines were recommended to be used in HEV high-risk population in the province.%目的 分析山东省人群戊型肝炎流行现状,为戊型肝炎防控提供参考.方法 于2014年10月,在山东省12个县(市、区)采用两阶段分层随机抽样方法,选取1~59岁常住人口作为调查对象.首先采用概率比例规模抽样法在调查县(市、区)抽取2个行政村/社区居委会,按照最适分配分层随机抽样方法抽取1~59岁人群,开展问卷调查并采集静脉血标本3~5 ml,共5229名.采用ELISA法检测戊型肝炎病毒(HEV)IgG抗体(抗-HEV IgG);采用抽样权重进行复杂抽样的抗-HEV IgG阳性率点值估计,采用泰勒级数线性法估计抗-HEV IgG阳性率的方差,然后构建估计值的95%CI.通过比较率点值的95%CI进行率的统计学检验.并与2006年山东省戊型肝炎血清流行病学调查结果相比较.结果 5229名调查对象的抗-HEV IgG阳性率为9.19%(95%CI:6.18%~12.20%),较2006年调查结果(11.47%,95%CI:8.92%~14.02%)下降19.88%;抗-HEV IgG阳性率随年龄增加而增高(χ2趋势=288.11,P<0.001),与2006年趋势相同.除1~4岁年龄组抗-HEV IgG与2006年基本持平外,其余各年龄组阳性率均低于2006年相应年龄组.2014年山东省城市人群抗-HEV IgG阳性率(8.19%,95%CI:0.00~22.23%)低于农村(9.69%,95%CI:4.99%~14.38%),东部(12.70%,95%CI:0.00~27.72%)高于中部(4.74%,95%CI:0.00~9.91%)和西部(9.32%,95%CI:0.69%~17.94%),且以上地区抗-HEV IgG阳性率均低于2006年相应地区(11.39%,95%CI:8.17%~14.62%;11.92%,95%CI:8.75%~15.08%;22.77%,95%CI:14.99%~30.55%;7.97%,95%CI:4.75%~11.20%;10.59%,95%CI:6.37%~14.82%).2014年沿海(16.56%,95%CI:12.94%~20.18%)、内陆(7.63%,95%CI:5.16%~10.10%)人群抗-HEV IgG阳性率均低于2006年(28.04%,95%CI:20.45%~35.64%;9.50%,95%CI:7.31%~11.70%).2014年,农民(11.98%,95%CI:8.20%~15.76%)、工人(9.68%,95%CI:4.48%~14.88%)、干部(13.90%,95%CI:7.47%~20.33%)、公共场所服务人员(12.26%,95%CI:1.80%~22.73%),抗-HEV IgG阳性率亦均低于2006年调查相应人群(13.76%,95%CI:10.15%~17.38%;21.11%,95%CI:12.67%~29.55%;17.81%,95%CI:7.63%~28.00%;21.08%,95%CI:0.03%~42.12%).结论 近年来山东省自然人群戊型肝炎阳性率有所下降,但流行特征未发生明显变化;人群易感性较高,应在高危人群中推广使用戊型肝炎疫苗.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号